Bulldog Investors’s ProKidney PROK Stock Holding History

Bulldog Investors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-153,378	Closed	-$1.53M	–	335
2022 Q2	$1.53M	Sell	153,378 -27,230	-15%	-$269K	0.42%	74
2022 Q1	$1.79M	Sell	180,608 -8,408	-4%	-$82.9K	0.46%	72
2021 Q4	$1.87M	Sell	189,016 -6,432	-3%	-$63.6K	0.5%	67
2021 Q3	$1.92M	Buy	+195,448	New	+$1.92M	0.54%	63

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Bulldog Investors's PROK Position: Q3 2022 in Review

Bulldog Investors sold out of ProKidney (PROK) in Q3 2022, closing a stake of 153,378 shares — an estimated $1.53M sold.

Bulldog Investors first reported a position in PROK in Q3 2021 and held it in 4 quarters. The position peaked at $1.92M in Q3 2021. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

Bulldog Investors reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
Bulldog Investors sold 153,378 ProKidney shares in Q3 2022, an estimated $1.53M.
Bulldog Investors first reported a position in ProKidney in Q3 2021 and held it in 4 quarters.
Bulldog Investors's ProKidney position peaked at $1.92M in Q3 2021.
18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Bulldog Investors's 13F filing for Q3 2022, filed 14 Nov 2022.